Florence Rochat
37Patents
12h-index
62Co-inventors
84Inventor score
Filing activity: Apr 28, 1995 → Dec 11, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7141554B2 | Method of treating irritable bowel syndrome | Human Necessities | 35 | Expired |
| US5952033A | Gelatinized cereal product containing oligosaccharide and processes of preparing and using same | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5603930A | Lactobacillus johnsonii CNCM I-1225 | Emerging Cross-Sectional Technologies | 31 | Expired |
| US5494664A | Bifidobacteria | Emerging Cross-Sectional Technologies | 27 | Expired |
| US6399124B1 | Frozen dessert containing lactic acid bacteria | Human Necessities | 27 | Expired |
| US7189390B2 | Probiotics for pet food applications | Emerging Cross-Sectional Technologies | 27 | Expired |
| US9192179B2 | Methods for promoting gut microbiota balance | Human Necessities | 25 | Active |
| US6926891B1 | Treatment of diarrhea with strains of Bifidobacterium longum | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6197361A | Gelatinized cereal product containing oligosaccharide | Emerging Cross-Sectional Technologies | 13 | Expired |
| US7767430B2 | Bifidobacteria preventing diarrhea caused by pathogenic bacteria | Emerging Cross-Sectional Technologies | 12 | Expired |
| US7101553B2 | Immune response enhancement methods | Human Necessities | 12 | Expired |
| US8394370B2 | Nutritional formula for optimal gut barrier function | Human Necessities | 12 | Expired |
| US8771675B2 | Probiotic strains for pets | Emerging Cross-Sectional Technologies | 11 | Active |
| US7029669B1 | Lactic acid bacteria strains capable of preventing diarrhoea | Emerging Cross-Sectional Technologies | 11 | Expired |
| US7771982B2 | Probiotics for pet food applications | Emerging Cross-Sectional Technologies | 10 | Active |
| US7381406B2 | Probiotic lactobacillus strains for pets | Emerging Cross-Sectional Technologies | 10 | Expired |
| US8092608B2 | Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters | Human Necessities | 9 | Expired |
| US8916145B2 | Use of Bifidobacterium longum for the prevention and treatment of inflammation | Human Necessities | 7 | Active |
| US6022568A | Ice cream with coating containing lactic acid bacteria | Human Necessities | 7 | Expired |
| US9060540B2 | Probiotics to increase IgA secretion in infants born by Caesarean section | Human Necessities | 6 | Active |
| US9131721B2 | Gut microbiota in infants | Human Necessities | 5 | Active |
| US6887465B1 | Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6596332B1 | Gelatinized cereal product containing oligosaccharide | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9414621B2 | Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings | Human Necessities | 2 | Active |
| US7091194B1 | Method for increasing the production of propionate in the gastrointestinal tract | Human Necessities | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.